Penetrance of Parkinson's Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk Score. Issue 5 (20th January 2020)
- Record Type:
- Journal Article
- Title:
- Penetrance of Parkinson's Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk Score. Issue 5 (20th January 2020)
- Main Title:
- Penetrance of Parkinson's Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk Score
- Authors:
- Iwaki, Hirotaka
Blauwendraat, Cornelis
Makarious, Mary B.
Bandrés‐Ciga, Sara
Leonard, Hampton L.
Gibbs, J. Raphael
Hernandez, Dena G.
Scholz, Sonja W.
Faghri, Faraz
Nalls, Mike A.
Singleton, Andrew B. - Other Names:
- Noyce Alastair J investigator.
Kaiyrzhanov Rauan investigator.
Middlehurst Ben investigator.
Kia Demis A investigator.
Tan Manuela investigator.
Houlden Henry investigator.
Morris Huw R investigator.
Plun‐Favreau Helene investigator.
Holmans Peter investigator.
Hardy John investigator.
Trabzuni Daniah investigator.
Quinn John investigator.
Bubb Vivien investigator.
Mok Kin Y investigator.
Kinghorn Kerri J. investigator.
Wood Nicholas W investigator.
Lewis Patrick investigator.
Schreglmann Sebastian investigator.
Lovering Ruth investigator.
R'Bibo Lea investigator.
Manzoni Claudia investigator.
Rizig Mie investigator.
Ryten Mina investigator.
Guelfi Sebastian investigator.
Escott‐Price Valentina investigator.
Chelban Viorica investigator.
Foltynie Thomas investigator.
Williams Nigel investigator.
Morrison Karen E. investigator.
Clarke Carl investigator.
Brice Alexis investigator.
Danjou Fabrice investigator.
Lesage Suzanne investigator.
Corvol Jean‐Christophe investigator.
Martinez Maria investigator.
Schulte Claudia investigator.
Brockmann Kathrin investigator.
Simón‐Sánchez Javier investigator.
Heutink Peter investigator.
Rizzu Patrizia investigator.
Sharma Manu investigator.
Gasser Thomas investigator.
Cookson Mark R investigator.
Bandres‐Ciga Sara investigator.
Blauwendraat Cornelis investigator.
Craig David W. investigator.
Billingsley Kimberley investigator.
Narendra Derek investigator.
Faghri Faraz investigator.
Raphael Gibbs J investigator.
Hernandez Dena G. investigator.
Keuren‐Jensen Kendall Van investigator.
Shulman Joshua M. investigator.
Iwaki Hirotaka investigator.
Leonard Hampton L. investigator.
Nalls Mike A. investigator.
Robak Laurie investigator.
Bras Jose investigator.
Guerreiro Rita investigator.
Lubbe Steven investigator.
Finkbeiner Steven investigator.
Mencacci Niccolo E. investigator.
Lungu Codrin investigator.
Singleton Andrew B investigator.
Scholz Sonja W. investigator.
Reed Xylena investigator.
Alcalay Roy N. investigator.
Gan‐Or Ziv investigator.
Rouleau Guy A. investigator.
Krohn Lynne investigator.
van Hilten Jacobus J investigator.
Marinus Johan investigator.
Adarmes‐Gómez Astrid D. investigator.
Aguilar Miquel investigator.
Alvarez Ignacio investigator.
Alvarez Victoria investigator.
Barrero Francisco Javier investigator.
Yarza Jesús Alberto Bergareche investigator.
Bernal‐Bernal Inmaculada investigator.
Blazquez Marta investigator.
Bonilla‐Toribio Marta investigator.
Botía Juan A. investigator.
Boungiorno María Teresa investigator.
Buiza‐Rueda Dolores investigator.
Cámara Ana investigator.
Carrillo Fátima investigator.
Carrión‐Claro Mario investigator.
Cerdan Debora investigator.
Clarimón Jordi investigator.
Compta Yaroslau investigator.
Diez‐Fairen Monica investigator.
Dols‐Icardo Oriol investigator.
Duarte Jacinto investigator.
Duran Raquel investigator.
Escamilla‐Sevilla Francisco investigator.
Ezquerra Mario investigator.
Feliz Cici investigator.
Fernández Manel investigator.
Fernández‐Santiago Rubén investigator.
Garcia Ciara investigator.
García‐Ruiz Pedro investigator.
Gómez‐Garre Pilar investigator.
Heredia Maria Jose Gomez investigator.
Gonzalez‐Aramburu Isabel investigator.
Pagola Ana Gorostidi investigator.
Hoenicka Janet investigator.
Infante Jon investigator.
Jesús Silvia investigator.
Jimenez‐Escrig Adriano investigator.
Kulisevsky Jaime investigator.
Labrador‐Espinosa Miguel A. investigator.
Lopez‐Sendon Jose Luis investigator.
de Munain Arregui Adolfo López investigator.
Macias Daniel investigator.
Torres Irene Martínez investigator.
Marín Juan investigator.
Marti Maria Jose investigator.
Martínez‐Castrillo Juan Carlos investigator.
Méndez‐del‐Barrio Carlota investigator.
González Manuel Menéndez investigator.
Mata Marina investigator.
Mínguez Adolfo investigator.
Mir Pablo investigator.
Rezola Elisabet Mondragon investigator.
Muñoz Esteban investigator.
Pagonabarraga Javier investigator.
Pastor Pau investigator.
Errazquin Francisco Perez investigator.
Periñán‐Tocino Teresa investigator.
Ruiz‐Martínez Javier investigator.
Ruz Clara investigator.
Rodriguez Antonio Sanchez investigator.
Sierra María investigator.
Suarez‐Sanmartin Esther investigator.
Tabernero Cesar investigator.
Tartari Juan Pablo investigator.
Tejera‐Parrado Cristina investigator.
Tolosa Eduard investigator.
Valldeoriola Francesc investigator.
Vargas‐González Laura investigator.
Vela Lydia investigator.
Vives Francisco investigator.
Zimprich Alexander investigator.
Pihlstrom Lasse investigator.
Toft Mathias investigator.
Koks Sulev investigator.
Taba Pille investigator.
Hassin‐Baer Sharon investigator.
Majamaa Kari investigator.
Siitonen Ari investigator.
Tienari Pentti investigator.
Okubadejo Njideka U. investigator.
Ojo Oluwadamilola O. investigator.
Kaiyrzhanov Coordinator ‐ Rauan investigator.
Shashkin Chingiz investigator.
Zharkinbekova Nazira investigator.
Akhmetzhanov Vadim investigator.
Aitkulova Akbota investigator.
Zholdybayeva Elena investigator.
Zharmukhanov Zharkyn investigator.
Kaishybayeva Gulnaz investigator.
Karimova Altynay investigator.
Sadykova Dinara investigator.
… (more) - Abstract:
- Abstract: Background: Although the leucine‐rich repeat kinase 2 p.G2019S mutation has been demonstrated to be a strong risk factor for PD, factors that contribute to penetrance among carriers, other than aging, have not been well identified. Objectives: To evaluate whether a cumulative genetic risk identified in the recent genome‐wide study is associated with penetrance of PD among p.G2019S mutation carriers. Methods: We included p.G2019S heterozygote carriers with European ancestry in three genetic cohorts in which the mutation carriers with and without PD were selectively recruited. We also included the carriers from two data sets: one from a case‐control setting without selection of mutation carriers and the other from a population sampling. Associations between polygenic risk score constructed from 89 variants reported recently and PD were tested and meta‐analyzed. We also explored the interaction of age and PRS. Results: After excluding eight homozygotes, 833 p.G2019S heterozygote carriers (439 PD and 394 unaffected) were analyzed. Polygenic risk score was associated with a higher penetrance of PD (odds ratio: 1.34; 95% confidence interval: [1.09, 1.64] per +1 standard deviation; P = 0.005). In addition, associations with polygenic risk score and penetrance were stronger in the younger participants (main effect: odds ratio 1.28 [1.04, 1.58] per +1 standard deviation; P = 0.022; interaction effect: odds ratio 0.78 [0.64, 0.94] per +1 standard deviation and + 10 years ofAbstract: Background: Although the leucine‐rich repeat kinase 2 p.G2019S mutation has been demonstrated to be a strong risk factor for PD, factors that contribute to penetrance among carriers, other than aging, have not been well identified. Objectives: To evaluate whether a cumulative genetic risk identified in the recent genome‐wide study is associated with penetrance of PD among p.G2019S mutation carriers. Methods: We included p.G2019S heterozygote carriers with European ancestry in three genetic cohorts in which the mutation carriers with and without PD were selectively recruited. We also included the carriers from two data sets: one from a case‐control setting without selection of mutation carriers and the other from a population sampling. Associations between polygenic risk score constructed from 89 variants reported recently and PD were tested and meta‐analyzed. We also explored the interaction of age and PRS. Results: After excluding eight homozygotes, 833 p.G2019S heterozygote carriers (439 PD and 394 unaffected) were analyzed. Polygenic risk score was associated with a higher penetrance of PD (odds ratio: 1.34; 95% confidence interval: [1.09, 1.64] per +1 standard deviation; P = 0.005). In addition, associations with polygenic risk score and penetrance were stronger in the younger participants (main effect: odds ratio 1.28 [1.04, 1.58] per +1 standard deviation; P = 0.022; interaction effect: odds ratio 0.78 [0.64, 0.94] per +1 standard deviation and + 10 years of age; P = 0.008). Conclusions: Our results suggest that there is a genetic contribution for penetrance of PD among p.G2019S carriers. These results have important etiological consequences and potential impact on the selection of subjects for clinical trials. © 2020 International Parkinson and Movement Disorder Society … (more)
- Is Part Of:
- Movement disorders. Volume 35:Issue 5(2020)
- Journal:
- Movement disorders
- Issue:
- Volume 35:Issue 5(2020)
- Issue Display:
- Volume 35, Issue 5 (2020)
- Year:
- 2020
- Volume:
- 35
- Issue:
- 5
- Issue Sort Value:
- 2020-0035-0005-0000
- Page Start:
- 774
- Page End:
- 780
- Publication Date:
- 2020-01-20
- Subjects:
- G2019S -- genetics -- LRRK2 -- Parkinson's disease -- polygenic risk score
Movement disorders -- Periodicals
610 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1531-8257 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/mds.27974 ↗
- Languages:
- English
- ISSNs:
- 0885-3185
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5980.317200
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13170.xml